Sanlao, Lumabao B.

HRN: 00-99-67  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/01/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/01/2026
03/08/2026
IV
500mg
Q8
Cholecystitis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominalProphylaxis    Compliance to guidelines: